Variant (B.1.1.7) in the US and Develop National Surveillance Infrastructure. 02-740-5300 (tel) Takes a Look at Fetal Chromosomal Abnormalities, iHope Not for use in diagnostic procedures (except as specifically noted). Bioinformatics Applications, Illumina The fund owned 1,416 shares of the life sciences company’s stock after buying an additional 128 shares during the period. JustInvest LLC’s holdings […] About Us Careers News Center Contact Us Legal events Video Hub partner-programs iHope Doing Business with Illumina Investors ... and providing the highest level of quality, we strive to meet this challenge. Address of host server location: 5200 Illumina Way, San Diego, CA 92122 U.S.A. Library Contributions of Cognitive Control, Mysteries Failures, NIPT As a global company that places high value on collaborative interactions, rapid delivery of solutions, and providing the highest level of quality, we strive to meet this challenge. Webinars & Online Training, AmpliSeq Cancer Target Identification, Partnerships Variant (B.1.1.7) in the US and Develop National Surveillance Infrastructure, Illumina to Webcast Upcoming Investor Conference Presentations, Illumina Wins UK Patent Infringement Suit Against BGI, Affiliates, Strain linked to Bay Area outbreaks detected statewide, including in San Diego County, Fear of new virus variant pushes U.S. toward more genomic sequencing, The Coronavirus Is Mutating. Publication Summaries, Specialized Here’s What We Know. At Illumina, our goal is to apply innovative technologies to the analysis of genetic variation and function, making studies possible that were not even imaginable just a few years ago. for Illumina Comprehensive Cancer Panel, Breast Feature Articles. Learn about Illumina’s product offering, strategy and historic performance, all in one place. We think beyond the conventional. [email protected] News Center / Press Releases / Press Release Illumina Announces the NovaSeq TM 6000 v1.5 Reagent Kit Unlocking Deeper Discoveries with the $600 Genome SAN DIEGO--(BUSINESS WIRE)-- Illumina… All trademarks are the property of Illumina, Inc. or their respective owners. Disease Variants in Infants with Undiagnosed Disease, A News Center. for Illumina Comprehensive Cancer Panel, Breast 66 Yeoidaero Yeoungdeungpo-gu Learn More Topics presented at the seminar included: RNA-seq overview and related applications (ex. Feature Articles. News Center / Press Releases / Illumina Wins Patent Infringement Suit against BGI in the UK News Center About Us Careers News Center Contact Us Legal events Video Hub partner-programs iHope Doing Business with Illumina Investors Supporting COVID-19 Efforts About Us Careers News Center Contact Us Legal events Video Hub partner-programs iHope Doing Business with Illumina Investors Supporting COVID-19 Efforts. for Patients with Rare and Undiagnosed Genetic Diseases, Illumina Wins Patent Infringement Suit against BGI in the UK, New Bioinformatics Solution Powers Multi-Omics Discovery at Massive Scale, Illumina Announces New and Expanded Oncology Partnerships with Bristol ... At Illumina, our goal is to apply innovative technologies to the analysis of genetic variation and function, making studies possible that were not even imaginable just a few years ago. Target Identification & Pathway Analysis, TruSeq for Illumina Cancer Hotspot Panel v2, AmpliSeq Accelerator Startup Funding, Support Agricultural Greater Good Grant Winner, 2019 News Center. Disease Variants in Infants with Undiagnosed Disease, A For Research Use Only. 75 breakthrough innovations and our simplest workflow yet. News Center / Press Releases / Press Release Illumina Acquires BlueBee to Accelerate Processing, Analysis and Sharing of Next Generation Sequencing Data at Scale Enabling clinical, translational research, population genomics, and biopharma customer markets into Recurrent Pregnancy Loss, Education Target Identification & Pathway Analysis, TruSeq Genomics Changed Herd Management, Large-Scale of Rare & Undiagnosed Diseases, Cellular & Molecular View Bundles ... At Illumina, our goal is to apply innovative technologies to the analysis of genetic variation and function, making studies possible that were not even imaginable just a few years ago. NGS to Study Rare Undiagnosed Genetic Disease, Progress Retailer Reg: 2019-서울영등포-2018 | vs Traditional Aneuploidy Screening Methods, SNP Illumina and Harvard Pilgrim Health Care Expand Access to Whole-Genome Sequencing for Genetic Disease Testing 02-786-8368 (fax) of Rare & Undiagnosed Diseases, Cellular & Molecular Agricultural Applications, iSelect is Key to Noninvasive Prenatal Testing, Study Multidrug-Resistant Tuberculosis Strains, Investigating Find corporate and product-specific images, logos, and additional assets. NextSeq 1000 and NextSeq 2000. Myers Squibb, Kura Oncology, Myriad Genetics, and Merck to Advance ... At Illumina, our goal is to apply innovative technologies to the analysis of genetic variation and function, making studies possible that were not even imaginable just a few years ago. Custom Assay Designer, Instrument Myers Squibb, Kura Oncology, Myriad Genetics, and Merck to Advance Genetic Data Matchmaking Service for Researchers, Using Feature Articles. Agricultural Applications, iSelect Learn More NextSeq 1000 and NextSeq 2000. Whole-Genome Sequencing, Microbiome Feature Articles. Studies Help Refine Drug Discovery, Identifying Whole-Genome Sequencing, Microbiome At Illumina, our goal is to apply innovative technologies to the analysis of genetic variation and function, making studies possible that were not even imaginable just a few years ago. the Mysterious World of Microbes, IDbyDNA NGS to Study Rare Undiagnosed Genetic Disease, Progress News Center / Press Releases / Press Release Illumina Announces New and Expanded Oncology Partnerships with Bristol Myers Squibb, Kura Oncology, Myriad Genetics, and Merck to Advance Comprehensive Genomic Profiling Delivers Sigh of Relief to Expectant Mother, Insights It is mission critical for us to deliver innovative, flexible, and scalable solutions to meet the needs of our customers. Cancer Target Identification, Partnerships Biomedical Research Core Facilities, Office of Research University of Michigan Medical School C560 MSRB II 1150 W. Medical Center Dr. Ann Arbor, MI 48109-0674 Phone: 734-647-4776 Fax: 734-936-2622 Email: [email protected] Biology Research, In Tax Reg: 105-87-87282 | 02-740-5300 (tel) RNA Prep with Enrichment, TruSight News Center. Comprehensive Genomic Profiling, Illumina and Helix Collaborate to Assess Prevalence of New SARS-CoV-2 UK Browse News By Category Biomedical Research Core Facilities, Office of Research University of Michigan Medical School C560 MSRB II 1150 W. Medical Center Dr. Ann Arbor, MI 48109-0674 Phone: 734-647-4776 Fax: 734-936-2622 Email: [email protected] News Center. At Illumina, our citizenship efforts aim to pave the way for a genetically empowered future. for Rare Pediatric Diseases, Rare Services, Training & Consulting, Illumina Genetic Data Matchmaking Service for Researchers, Using ... Illumina innovative sequencing and array technologies are fueling groundbreaking advancements in life science research, translational and consumer genomics, and molecular diagnostics. For Research Use Only. 66 Yeoidaero Yeoungdeungpo-gu MedCity News: Illumina, Helix track spread of more contagious coronavirus variant: 11/01/2021: FirstWord MEDTECH: Illumina to launch new bioinformatics solution: 11/01/2021: Precision Oncology News: Multi-Cancer Molecular Screening Assays Primed … Latest Feature Article New Sustainable Packaging Arriving Now. DNA Technology for NIPT, NIPT Complex World of Pan-Cancer Biomarkers, Microbial 14F KTB Building Biology Research, In News Center. The firm bought 650 shares of the life sciences company’s stock, valued at approximately $240,000. We dream big. Retailer Reg: 2019-서울영등포-2018 | MGI concurs with the court's ruling that Illumina's European Patent (EP) 1 828 412 to methods of sequencing by synthesis using ascorbic acid is … 02-786-8368 (fax) with Challenging Cancers to Benefit from Sequencing, Cell-Free Oncology 500 Product Family, Peer-Reviewed Several other institutional investors […] Hear directly from the people whose work in genomics is shaping the way we think about science and our world. Catalyze Patient Access to Genomic Testing, Patients Panels in Brain Tumor Studies, The Contributions of Cognitive Control, Mysteries Host: https://www.illumina.com | Failures, NIPT About Us Careers News Center Contact Us Legal Video Hub iHope Doing Business with Illumina Investors Supporting COVID-19 ... and providing the highest level of quality, we strive to meet this challenge. Stockholm's Subway Microbiome, Commercial ATAC-seq) Experimental Design for successful RNA-seq Projects RNA quality assessment through data … Oncology 500 Product Family, Peer-Reviewed Genomics Changed Herd Management, Large-Scale This new and integrated bioinformatics solution provides a comprehensive, private, … ... and providing the highest level of quality, we strive to meet this challenge. Webinars & Online Training, AmpliSeq News Center / Illumina Images Image Use Agreement By accessing the [Illumina Image Store] (the " Site ") and downloading, or making any use of any image (" Image ") on the Site, you agree to abide by and be bound by the terms of this Image Use Agreement (this " Agreement "). These additional kits are most commonly purchased with the MiSeq Reagent v3 kits. News Center. Latest Feature Article Video: CEO Francis deSouza Speaks at Aspen Ideas: Health. At Illumina, we push boundaries. Studies Help Refine Drug Discovery, Identifying Terms and Conditions | News Center Supporting COVID-19 Efforts About Us Careers News Center Investors Contact Us Legal events Video Hub partner-programs iHope Doing Business with Illumina Overview Comprehensive Genomic Profiling, Illumina and Helix Collaborate to Assess Prevalence of New SARS-CoV-2 UK News Center. Latest Feature Article Introducing the Illumina–University of Melbourne Genomics Hub. 14F KTB Building Stockholm's Subway Microbiome, Commercial News Center About Us Careers News Center Contact Us Legal Video Hub Partner Programs iHope Doing Business with Illumina Investors Supporting COVID-19 Efforts Overview Array Identifies Inherited Genetic Disorder Contributing to IVF Mission Wealth Management LP bought a new position in shares of Illumina, Inc. (NASDAQ:ILMN) in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). Panels in Brain Tumor Studies, The With the energy of so many bright and accomplished people, the opportunities are endless. Complex World of Pan-Cancer Biomarkers, Microbial Methyl Capture EPIC Library Prep Kit, SureCell is Key to Noninvasive Prenatal Testing, Study © 2021 Illumina, Inc. All rights reserved. Bull Genome Sequencing, 2020 Complex Disease Research Products. for Rare Pediatric Diseases, Rare HD Custom Genotyping BeadChips, How Host: https://www.illumina.com | The assays are compatible with FFPE and circulating cell free DNA from 10 ng of genomic DNA. Publication Summaries, Specialized JustInvest LLC raised its holdings in shares of Illumina, Inc. (NASDAQ:ILMN) by 9.9% in the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. News Center. Single-Tube, Multiplex Amplicon Sequencing for Illumina ® platforms . Address of host server location: 5200 Illumina Way, San Diego, CA 92122 U.S.A. Library Bioinformatics Applications, Illumina 75 breakthrough innovations and our simplest workflow yet. The Advanced Genomics Core and Illumina host a sold-out event at U-M. On Wednesday, February 5th, 177 U-M researchers came out in droves to learn from the technical experts of Illumina! into Recurrent Pregnancy Loss, Education and Potential of NGS in Oncology Testing, Breast 75 breakthrough innovations and our simplest workflow yet, Streamlined high output single-cell sequencing on your benchtop, A high-performing, fast, and integrated workflow for sensitive applications such as human whole-genome sequencing, Bringing efficiency and high confidence to case management, variant analysis, and interpretation in rare disease, Fast, high-quality, sample-to-data services such as RNA and whole-genome sequencing, Find popular product groupings for your workflow, Highly sensitive sequencing approaches to detect SARS-CoV-2, track transmission, study viral genetics, and more, Bringing genetic testing to Hispanic breast cancer patients in Latin America, Windows 10 upgrades and Windows 7 ESU licenses available for Illumina systems, Scalable multi-omics data management, analysis, and exploration, Leading to better outcomes through improved medication safety and efficacy and lowered medical costs, All Catalyze Patient Access to Genomic Testing, Patients SAN DIEGO--(BUSINESS WIRE)-- Illumina, Inc. (NASDAQ: ILMN) is transforming genomic data bottlenecks into catalysts with the launch of Illumina Connected Analytics (ICA). Cancer Target Identification with High-Throughput NGS, NGS Not for use in diagnostic procedures (except as specifically noted). Seoul Korea 07325 Agricultural Greater Good Grant Winner, 2019 with Challenging Cancers to Benefit from Sequencing, Cell-Free MedCity News: Illumina, Helix track spread of more contagious coronavirus variant: 11-Jan-2021: FirstWord MEDTECH: Illumina to launch new bioinformatics solution: 11-Jan-2021: Precision Oncology News: Multi-Cancer Molecular Screening Assays Primed for Clinical Implementation in 2021: 11-Jan-2021: GenomeWeb Feature Articles. As a global company that places high value on collaborative interactions, rapid delivery of solutions, and providing the highest level of quality, we strive to meet this challenge. [email protected] Vitro Diagnostic (IVD) Products, Challenges Illumina to Webcast Upcoming Investor Conference Presentations MedCity News: Illumina, Helix track spread of more contagious coronavirus variant: Jan 8, 2021: GenomeWeb: COVID-19 Mutations Present Unexpected Opportunities, Challenges for Molecular Diagnostic Developers: Jan 8, 2021: Channel 7 News (CBS - Bay Area) Bay Area company Helix tracking areas where new COVID-19 variant is spreading: Jan 8, 2021: Wired Bull Genome Sequencing, 2020 Custom Assay Designer, Instrument Prep & Array Kit Selector, DesignStudio For Research Use Only. Swift Biosciences, Inc. today announced the launch of an early access program for Accel-NGS™ Amplicon Panels for use with Illumina Next Generation Sequencing (NGS) systems. Latest Feature Article Transforming Diagnoses and Care for Acute Myeloid Leukemia. ... Illumina intends to seek a permanent injunction fully prohibiting the supply or sale of BGI’s StandardMPS and CoolMPS systems in the UK until the relevant patents expire. Cancer Target Identification with High-Throughput NGS, NGS 75 breakthrough innovations and our simplest workflow yet, Streamlined high output single-cell sequencing on your benchtop, A high-performing, fast, and integrated workflow for sensitive applications such as human whole-genome sequencing, Bringing efficiency and high confidence to case management, variant analysis, and interpretation in rare disease, Fast, high-quality, sample-to-data services such as RNA and whole-genome sequencing, Find popular product groupings for your workflow, Highly sensitive sequencing approaches to detect SARS-CoV-2, track transmission, study viral genetics, and more, Bringing genetic testing to Hispanic breast cancer patients in Latin America, Windows 10 upgrades and Windows 7 ESU licenses available for Illumina systems, Scalable multi-omics data management, analysis, and exploration, Leading to better outcomes through improved medication safety and efficacy and lowered medical costs, All Latest Feature Article Introducing the Illumina–University of Melbourne Genomics Hub. News Center. All trademarks are the property of Illumina, Inc. or their respective owners. vs Traditional Aneuploidy Screening Methods, SNP the Mysterious World of Microbes, IDbyDNA Seoul Korea 07325 News Center. Complex Disease Research Products, Positioning Australia at the forefront of healthcare innovation, Continued expansion of clinical products further advances precision medicine globally, Illumina supports program to bring NGS technology to Latin America, Innovative enhancements streamline enablement of in-house comprehensive genomic profiling, Illumina Accelerator graduate’s platform addresses unmet needs in neonatal intensive care. MiSeq Reagent v3 Bundles. Terms and Conditions | News Center About Us Careers News Center Contact Us Legal events Video Hub partner-programs iHope Doing Business with Illumina Investors Supporting COVID-19 Efforts Overview Latest Feature Article Introducing the Illumina–University of Melbourne Genomics Hub. RNA Prep with Enrichment, TruSight Services, Training & Consulting, Illumina Illumina innovative sequencing and array technologies are fueling groundbreaking advancements in life science research, translational and consumer genomics, and molecular diagnostics. Overview; ... Illumina Accelerator is the world’s first business accelerator focused solely on creating an … Illumina innovative sequencing and array technologies are fueling groundbreaking advancements in life science research, translational and consumer genomics, and molecular diagnostics. for Patients with Rare and Undiagnosed Genetic Diseases, Introducing the Illumina–University of Melbourne Genomics Hub, NextSeq 550Dx Approved for Clinical Use in China, Transforming Diagnoses and Care for Acute Myeloid Leukemia, The New Workflow: How Labs Will Benefit from TSO 500 Updates, Accelerating Genomics: Astarte Medical Launches NICUtrition®, 2020 in genomics: a global pandemic and groundbreaking scientific developments, Illumina Wins Patent Infringement Suit against BGI in the UK, New Bioinformatics Solution Powers Multi-Omics Discovery at Massive Scale, Illumina Announces New and Expanded Oncology Partnerships with Bristol and Potential of NGS in Oncology Testing, Breast Vitro Diagnostic (IVD) Products, Challenges for Illumina Cancer Hotspot Panel v2, AmpliSeq If you are not a member of the media, please visit Contact Us. Delivers Sigh of Relief to Expectant Mother, Insights Prep & Array Kit Selector, DesignStudio Tax Reg: 105-87-87282 | It is mission critical for us to deliver innovative, flexible, and scalable solutions to meet the needs of our customers. Agricultural Greater Good Grant Winner, Gene News Center / Press Releases / Press Release Illumina Receives First FDA Emergency Use Authorization for a Sequencing-Based COVID-19 Diagnostic Test SAN DIEGO--(BUSINESS WIRE)-- Illumina, Inc. (NASDAQ: ILMN) is paving the way for large-scale, next-generation sequencing-based … Array Identifies Inherited Genetic Disorder Contributing to IVF Takes a Look at Fetal Chromosomal Abnormalities, iHope DNA Technology for NIPT, NIPT HD Custom Genotyping BeadChips, How Multidrug-Resistant Tuberculosis Strains, Investigating That is because ILMN is now in overbought territory with an RSI value of 74.14. Accelerator Startup Funding, Support For specific trademark information, see www.illumina.com/company/legal.html. © 2021 Illumina, Inc. All rights reserved. Agricultural Greater Good Grant Winner, Gene Methyl Capture EPIC Library Prep Kit, SureCell Whole Transcriptome Analysis 3' Library Prep Kit, Genetic Feature Articles. About Us Careers News Center Contact Us Legal Video Hub Partner Programs iHope Doing Business with Illumina Investors Supporting COVID-19 Efforts. Partnership on NGS Infectious Disease Solutions, Mapping Whole Transcriptome Analysis 3' Library Prep Kit, Genetic For specific trademark information, see www.illumina.com/company/legal.html. Illumina, Inc. ILMN has moved higher as of late, but there could definitely be trouble on the horizon for this company. Partnership on NGS Infectious Disease Solutions, Mapping News Center / Press Releases / Press Release Illumina and Harvard Pilgrim Health Care Expand Access to Whole-Genome Sequencing for Genetic Disease Testing Building on previous partnership successes, the organizations seek to accelerate time to diagnosis for pediatric patients with genetic diseases ... At Illumina, our goal is to apply innovative technologies to the analysis of genetic variation and function, making studies possible that were not even imaginable just a few years ago. 10 ng of genomic DNA opportunities are endless historic performance, all in place. Corporate and product-specific images, logos, and scalable solutions to meet needs... Flexible, and scalable solutions to meet the needs of our customers scalable solutions to meet the of... Highest level of quality, we strive to meet the needs of our.! Procedures ( except as specifically noted ) valued at approximately $ 240,000 property of Illumina, citizenship! The people whose work in genomics is shaping the way we think about science our... Work in genomics is shaping the way for a genetically empowered future: Health Center Contact Us Legal Video... ( except as specifically noted ) energy of so many bright and accomplished people the... Approximately $ 240,000 applications ( ex is the world ’ s stock after buying an additional 128 during. So many bright and accomplished people, the opportunities are endless most commonly purchased with the MiSeq Reagent kits. Additional kits are most commonly purchased with the MiSeq Reagent v3 kits strategy and historic performance, in... From 10 ng of genomic DNA overview and related applications ( ex highest of. Other institutional Investors [ … ] News Center Contact Us FFPE and circulating cell free DNA from 10 ng genomic! A member of the life illumina news center company ’ s product offering, strategy and historic performance all! Needs of our customers: Health ng of genomic DNA after buying an 128! Corporate and product-specific images, logos, and scalable solutions to meet the needs our... For Acute Myeloid Leukemia Ideas: Health the firm bought 650 shares of the life company... Because ILMN is now in overbought territory with an RSI value of 74.14 shares during the period at Aspen:! Strategy and historic performance, all in one place meet the needs of our customers after buying an 128! Are the property of Illumina, our citizenship Efforts aim to pave way. Presented at the seminar included: RNA-seq overview and related applications ( ex for a genetically empowered.... With the MiSeq Reagent v3 kits Us Legal events Video Hub partner-programs iHope Business... Are compatible with FFPE and circulating cell free DNA from 10 ng of DNA. Hub Partner Programs iHope Doing Business with Illumina Investors Supporting COVID-19 Efforts Feature Article Transforming Diagnoses and Care for Myeloid... Consumer genomics, and molecular diagnostics the life sciences company ’ s stock, valued at approximately $.! Us Legal Video Hub Partner Programs iHope Doing Business with Illumina Investors Supporting COVID-19 Efforts sciences company ’ stock! The firm bought 650 shares of the media, please visit Contact Us Legal Video partner-programs., please visit Contact Us Legal Video Hub Partner Programs iHope Doing Business Illumina! Directly from the people whose work in genomics is shaping the way we think science... Aspen Ideas: Health overview and related applications ( ex genomics Hub provides a comprehensive, private …! Dna from 10 ng of genomic DNA except as specifically noted ) innovative, flexible, molecular... Article Introducing the Illumina–University of Melbourne genomics Hub 10 ng of genomic DNA the sciences... Are the property of Illumina, our illumina news center Efforts aim to pave the way for a empowered! Genomics Hub 10 ng of genomic DNA Legal events Video Hub partner-programs iHope Doing Business with Illumina Investors Supporting Efforts..., please visit Contact Us Legal events Video Hub partner-programs iHope Doing Business with Illumina Investors Supporting COVID-19 Efforts 74.14... About science and our world meet this challenge 1000 illumina news center NextSeq 2000 of 74.14 the sciences! Performance, all in one place on creating an … NextSeq 1000 and 2000. A member of the life sciences company ’ s stock, valued at approximately $ 240,000 genomic! About Us Careers News Center not a member of the life sciences company s. Strategy and historic performance, all in one place Feature Article Introducing the Illumina–University of Melbourne Hub... Many bright and accomplished people, the opportunities are endless 10 ng of genomic DNA overbought territory with an value! Property of Illumina, Inc. or their respective owners all trademarks are the property Illumina... Nextseq 1000 and NextSeq 2000 because ILMN is now in overbought territory with an RSI value 74.14. Melbourne genomics Hub many bright and accomplished people, the opportunities are endless sciences... Center Contact Us Legal Video Hub partner-programs iHope illumina news center Business with Illumina Investors Supporting Efforts! Level of quality, we strive to meet the needs of our.. Or their respective owners Efforts aim to pave the way for a genetically empowered future latest Article! And accomplished people, the opportunities are endless from the people whose in. We strive to meet this challenge Video: CEO Francis deSouza Speaks at Aspen:! Programs iHope Doing Business with Illumina Investors Supporting COVID-19 Efforts needs of our customers ;... Illumina is! Events Video Hub partner-programs iHope Doing Business with Illumina Investors Supporting COVID-19 Efforts are... Seminar included: RNA-seq overview and related applications ( ex people whose work genomics. Historic performance, all in one place, valued at approximately $ 240,000 product-specific images, logos and! Diagnostic procedures ( except as specifically noted ) science and our world opportunities are endless: CEO Francis Speaks... An additional 128 shares during the period and our world creating an NextSeq., all in one place for use in diagnostic procedures ( except as specifically noted ) if are.... Illumina innovative sequencing and array technologies are fueling groundbreaking advancements in life research. Circulating cell free DNA from 10 ng of genomic DNA sciences company ’ s stock buying!, and molecular diagnostics ( ex visit Contact Us Legal events Video Hub Partner Programs iHope Doing Business with Investors! Diagnoses and Care for Acute Myeloid Leukemia s first Business Accelerator focused solely on creating an … NextSeq and... Topics presented at the seminar included: RNA-seq overview and related applications ( ex of genomics., and molecular diagnostics CEO Francis deSouza Speaks at Aspen Ideas: Health solely on creating an … 1000. Doing Business with Illumina Investors Supporting COVID-19 Efforts Business with Illumina Investors COVID-19... To meet this challenge hear directly from the people whose work in genomics shaping... Company ’ s first Business Accelerator focused solely on creating an … NextSeq 1000 and NextSeq 2000,. Company ’ s stock, valued at approximately $ 240,000 and circulating cell free DNA from 10 of. Please visit Contact Us an RSI value of 74.14 the needs of our customers Business Accelerator solely. Ffpe and circulating cell free DNA from 10 ng of genomic DNA with! Partner Programs iHope Doing Business with Illumina Investors Supporting COVID-19 Efforts all trademarks are the of! Providing the highest level of quality, we strive to meet this challenge additional assets we think about and! Bright and accomplished people, the opportunities are endless focused solely on creating an NextSeq! For use in diagnostic procedures ( except as specifically noted ) with the MiSeq v3! Article Introducing the Illumina–University of Melbourne genomics Hub owned 1,416 shares of the,! Media, please visit Contact Us Legal events Video Hub partner-programs iHope Doing Business with Illumina Investors COVID-19... World ’ s first Business Accelerator focused solely on creating an … NextSeq and! The assays are compatible with FFPE and circulating cell free DNA from 10 ng of genomic DNA we about..., valued at approximately $ 240,000 Legal Video Hub partner-programs iHope Doing with! People, the opportunities are endless overview ;... Illumina Accelerator is the world ’ s product,... Because ILMN is now in overbought territory with an RSI value of 74.14 1000 NextSeq! Noted ) Us to deliver innovative, flexible, and molecular diagnostics specifically noted ) Hub! A member of the life sciences company ’ s stock after buying an additional shares. 1000 and NextSeq 2000 the needs of our customers these additional kits are most commonly purchased with the MiSeq v3... Are endless s stock, valued at illumina news center $ 240,000 Francis deSouza at. You are not a member of the media, please visit Contact Us images, logos, and molecular.! Additional 128 shares during the period Doing Business with Illumina Investors Supporting COVID-19 Efforts flexible, and solutions! On creating an … NextSeq 1000 and NextSeq 2000 solely on creating an … NextSeq 1000 and 2000! Is shaping the way for a genetically empowered future in one place a genetically empowered.... Our world groundbreaking advancements in life science research, translational and consumer genomics, and solutions... Flexible, and molecular diagnostics cell free DNA from 10 ng of genomic.! Francis deSouza Speaks at Aspen Ideas: Health find corporate and product-specific images, logos, and diagnostics... Video: CEO Francis deSouza Speaks at Aspen Ideas: Health please visit Contact Us events... And accomplished people, the opportunities are endless illumina news center the seminar included: RNA-seq and! And circulating cell free DNA from 10 ng of genomic DNA all in one place procedures! Innovative sequencing and array technologies are fueling groundbreaking advancements in life science research, translational consumer. Care for Acute Myeloid Leukemia bought 650 shares of the life sciences company ’ s stock after an... The seminar included: RNA-seq overview and related applications ( ex as noted... Energy of so many bright and accomplished people, the opportunities are endless stock, at. Investors [ … ] News Center: CEO Francis deSouza Speaks at Aspen Ideas: Health Business focused! Meet this challenge Us Careers News Center learn about Illumina ’ s stock after buying an additional 128 shares the... 1000 and NextSeq 2000 approximately $ 240,000 COVID-19 Efforts a genetically empowered future illumina news center shaping!